News, Alerts, and Opinions

Headline Source Date
Precision Therapeutics’ Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research GlobeNewswire 04/18/19 EDT
Precision Therapeutics’ Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Receive Alberta Innovates Product Demonstration Program Grant to Support Development of Novel Cancer Treatments GlobeNewswire 04/16/19 EDT
Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine Opportunities for Cancer Patients GlobeNewswire 04/11/19 EDT
Uptick Newswire Hosts Precision Therapeutics Inc. on The Stock Day Podcast to Discuss Massive Revenue Increases Accesswire 04/11/19 EDT
Precision Therapeutics’ Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovarian Cancer GlobeNewswire 04/09/19 EDT
Precision Therapeutics Announces Completion of Merger with Helomics Holding Corporation GlobeNewswire 04/05/19 EDT
Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update GlobeNewswire 04/01/19 EDT
Dawson James Securities Announces the Closing of Public Offering for Precision Therapeutics Inc. GlobeNewswire 04/01/19 EDT
Precision Therapeutics Inc. Announces Pricing of Public Offering of Up to $1.2 Million of Units GlobeNewswire 03/27/19 EDT
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities GlobeNewswire 03/26/19 EDT
Precision Therapeutics Announces Results of Special Meeting of Stockholders GlobeNewswire 03/25/19 EDT
Precision Therapeutics to Report Fiscal Year 2018 Financial Results and Provide Company Update on Monday, April 1, 2019 GlobeNewswire 03/25/19 EDT
Viome and Helomics Partner to Identify Personalized Treatment for Ovarian Cancer Patients PR Newswire 03/21/19 EDT